- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00188435
Comparison of CXR and MnDCT
April 23, 2007 updated by: University Health Network, Toronto
A Comparison of Chest Radiography and Minimum Dose Chest CT
A comparison of chest x-ray (CXR) and Minimum dose CT (MnDCT) in the acutely ill patient.
The hypothesis is that MnDCT is more sensitive than CXR in the detection of acute findings in the acutely ill patient.
Study Overview
Detailed Description
A comparison of chest x-ray (CXR) and Minimum dose CT (MnDCT) in a cohort of 100 patients admitted for acute respiratory distress.
Chest radiography (CXR) is compared to Minimum Dose CT (MnDCT) for the detection of consolidation;lung nodules, heart failure.
Study Type
Interventional
Enrollment
100
Phase
- Phase 1
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All patients admitted for investigation of acute pulmonary embolus
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
A comparison of CXr and MnDCT in the detection of acute findings within the thorax
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Narinder Paul, FRCP C, University Health Network, Toronto
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2003
Study Completion
December 1, 2004
Study Registration Dates
First Submitted
September 12, 2005
First Submitted That Met QC Criteria
September 12, 2005
First Posted (Estimate)
September 16, 2005
Study Record Updates
Last Update Posted (Estimate)
April 24, 2007
Last Update Submitted That Met QC Criteria
April 23, 2007
Last Verified
September 1, 2005
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 03-0731
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Dyspnoea
-
University of OxfordCompleted
-
AstraZenecaCompletedBleeding ,Arrhythmias, Heart Failure, Acute Renal Failure, Acute Liver Failure, Dyspnoea, GoutSweden
-
Bitop AGCompletedCough | Bronchitis | Dyspnoea | Sputum, Cellular AtypiaGermany
-
Odense University HospitalUniversity of Southern DenmarkCompletedCough | Chest Pain | DyspnoeaDenmark
-
Mahatma Gandhi Institute of Medical SciencesUnknownHeart Failure | Congestive Cardiac Failure | DyspnoeaIndia
-
University of East AngliaInterMuneUnknownDepression | Anxiety | Idiopathic Pulmonary Fibrosis | DyspnoeaUnited Kingdom
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia With Maturation | Adult Acute Myeloid Leukemia Without Maturation | Adult Acute Myelomonocytic Leukemia | Alkylating Agent-Related Acute Myeloid... and other conditionsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Erythroleukemia (M6) | Childhood Acute Megakaryocytic Leukemia (M7) | Childhood Acute Monoblastic Leukemia (M5a) | Childhood Acute Monocytic Leukemia (M5b) | Childhood Acute Myeloblastic Leukemia With Maturation (M2) | Childhood Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
Clinical Trials on Minimum Dose CT
-
University Health Network, TorontoCompletedNon-small Cell Lung CancerCanada
-
Seoul National University Bundang HospitalGE Healthcare; National Research Foundation of KoreaCompletedAppendicitisKorea, Republic of
-
Kyoung Ho Lee, MDSeoul National University Bundang Hospital; Ministry of Health & Welfare, Korea and other collaboratorsCompleted
-
Seoul National University HospitalActive, not recruiting
-
Yale UniversityAgency for Healthcare Research and Quality (AHRQ)Completed
-
Sang-Won UmNot yet recruitingHealth Risk Behaviors
-
University Hospital, GenevaCompleted
-
Oncology Teaching Hospital, BaghdadEnrolling by invitation
-
Cantonal Hospital of St. GallenUnknownPulmonary Emphysema | Multiple Pulmonary NodulesSwitzerland
-
Hospices Civils de LyonCompletedTelangiectasia, Hereditary Hemorrhagic | Rendu Osler DiseaseFrance